Products and methods for the diagnosis and differentiation of heparin-induced thrombocytopenia from vaccine-induced immune thrombotic thrombocytopenia and non-heparin-induced thrombocytopenia

Abstract

Described are mutant Platelet Factor 4 (PF4) proteins that exhibit different binding affinities to vaccine induced immune thrombotic thrombocytopenia (VITT) antibodies or non-heparin-induced thrombocytopenia (non-HIT) antibodies relative to heparin-induced thrombocytopenia (HIT) antibodies. Also provided herein are methods for differentiating between VITT, HIT, and/or non-HIT in subjects suspected of having VITT, HIT, or non-HIT.

Dependencies are inferred from the claim text.